8-K: BioCardia Faces Nasdaq Delisting Warning Over Share Price

BioCardia, Inc. received a notice from Nasdaq indicating its common stock has fallen below the $1.00 minimum bid price requirement, triggering a 180-day compliance period.

Summary

• BioCardia, Inc. received a notice from Nasdaq on August 19, 2026, stating that its common stock has traded below the $1.00 per share minimum for 30 consecutive business days.
• The company has been granted an initial period of 180 days, until February 16, 2027, to regain compliance with the Minimum Bid Price Requirement.
• Compliance can be achieved if the closing bid price of the common stock is $1.00 or more for at least ten consecutive business days before February 16, 2027.
• If compliance is not met by the deadline, the company may be eligible for an additional 180 days, provided it meets other listing requirements and intends to cure the deficiency, potentially through a reverse stock split.
• Failure to regain compliance within the extended period could lead to the delisting of the company's common stock from the Nasdaq Capital Market.
• The company is actively monitoring its stock price and considering options to regain compliance.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development due to the notice of potential delisting from Nasdaq, indicating significant financial distress.

Positives

• The company has been granted a 180-day compliance period to address the minimum bid price issue.
• The notice has no immediate effect on the listing or trading of the company's common stock.
• The company may be eligible for an additional 180-day compliance period if certain conditions are met.

Negatives

• The company's common stock has fallen below the $1.00 minimum bid price requirement for 30 consecutive business days.
• There is a risk of delisting from the Nasdaq Capital Market if compliance is not achieved by February 16, 2027.
• There is no assurance that the company will regain compliance or secure an extension.

Risks

• The risk that the company may not meet the Minimum Bid Price Requirement by February 16, 2027.
• The risk that the company may not otherwise meet the requirements for continued listing under the Nasdaq Listing Rules.
• The risk that Nasdaq may not grant the company relief from delisting if necessary.
• The risk that the company may not ultimately meet applicable Nasdaq requirements if any such relief is necessary.

Future Outlook

The company intends to actively monitor its stock price and may consider available options to regain compliance with the Minimum Bid Price Requirement. There is no assurance of regaining compliance or maintaining other listing requirements.

Management Comments

• The Company intends to actively monitor the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance with the Minimum Bid Price Requirement.
• There can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement during the 180-day compliance period ending February 16, 2027, secure an extension of the compliance period beyond February 16, 2027 or maintain compliance with any other Nasdaq listing requirements.

Industry Context

StockSavvy.ai notes that Nasdaq delisting warnings due to low share prices are a common concern for smaller-cap companies, often signaling underlying business challenges or investor sentiment issues.

Stakeholder Impact

• Shareholders: Potential for significant decline in stock value and risk of delisting, which could reduce liquidity and investor confidence.
• Creditors: Increased risk associated with the company's financial stability and ability to meet obligations if delisted.
• Employees: Potential impact on morale and job security due to financial distress and uncertainty.

Next Steps

• Actively monitor the closing bid price of its common stock.
• Consider available options to regain compliance with the Minimum Bid Price Requirement.
• If necessary, meet continued listing requirements for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market to qualify for an additional compliance period.
• Provide written notice of intention to cure the deficiency during the second compliance period, potentially by effecting a reverse stock split.

Key Dates

Recommendation

The notice from Nasdaq regarding the minimum bid price requirement and the potential for delisting indicates significant financial distress and a negative outlook for the company's stock. The lack of immediate positive catalysts and the substantial risks associated with regaining compliance suggest a sell recommendation.

Keywords

Nasdaq delisting, minimum bid price, compliance period, stock price, listing requirements, reverse stock split, common stock